critical care management of increase intracranial pressure
DESCRIPTION
Critical care management of Increase Intracranial Pressure. พญ.อิศ รา ภรณ์ พูนสวัสดิ์ พบ. Aitsaraporn Phunsawat MD. Department of anesthesiology, Faculty of medicine Naresaun University Hospital. Anatomy of the cranium. Cranium is a rigid box containing 1. brain 80% (1300 ml) - PowerPoint PPT PresentationTRANSCRIPT
Critical care management of
Increase Intracranial Pressure
พญ.อิศราภรณ์ พูนสวสัดิ์ พบ.A I T S A R A P O R N P H U N S AW A T M D .
D E PA R T M E N T O F A N E S T H E S I O L O G Y, FA C U L T Y O F M E D I C I N E
N A R E S A U N U N I V E R S I T Y H O S P I T A L
Anatomy of the cranium Cranium is a rigid box containing
1. brain 80% (1300 ml)2. blood 12% (110 ml)3. CSF 8% (65 ml)
All of these contents are maintained a balanced pressure referred to as
intracranial pressure (ICP)
Intracranial pressure
Best Practice & Research Clinical Anaesthesiology.2007;21: 517–38
The normal range for ICP varies with ageAge group ICP normal (mmHg)
Infant < 7.5Child < 10Adult < 15
(7.5 -20 cm H2O)
Intracranial pressure Transient elevation with straining,
coughing, or trendelenberg position Sustained ICP ≥20: abnormal ICP 20-40mmHg : moderate ICH
(intracranial hypertension) Sustained ICP ≥ 40 mm Hg indicate
severe, life-threatening ICH
Neurol Clin 2008;26: 521–41
Goal: Keep ICP≤ 20 mmHg
Monro-Kellie Doctrine(Compensatory mechanism)
The skull is a rigid bowl that offers little flexibility for changes in the size of the three intracranial components. To maintain normal pressure in the skull, any increase in the size of one component initially will lead to a compensatory decrease in one or both of the other two.
Brain displaced to moderate degrees to
accommodate an expanding mass. Slow expansion Rapid expansion
Cerebral herniation1.Subfalcine 2.Uncal transtentorial3.Tonsillar4.Trancalvarial5.Transtentorial(Central)6.Upward transtentorial
Adverse effect of ICH
Decreased CPP Brain ishemia brain edema
increase ICP Brain herniation
Conditions Associated with Increased ICP
Subdural hematoma Epidural hematoma Brain tumor Cerebral abscess Intracerebral
hemorrhage
Cerebral infarction Global hypoxia-
ischemia Reye's syndrome Acute hyponatremia
Intracranial mass lesions
Increased brain volume (cytotoxic edema)
Conditions Associated with Increased ICP
Hepatic encephalopathy Traumatic brain injury Meningitis Encephalitis Hypertensive encephalopathy Eclampsia Subarachnoid hemorrhage Dural sinus thrombosis Altitude-related cerebral
edema
Communicating hydrocephalus
Noncommunicating hydrocephalus
Choroid plexus papilloma
Increased blood and brain volume
(vasogenic edema)Increased CSF volume
Extracranial cause (secondary) Prevent
cause, Prevent ICH
Clinical Signs of Increased
ICP
Clinical Signs of Increased ICP
Signs which are almost always present Depressed level of consciousness (lethargy, stupor,
coma) Hypertension, with or without bradycardia Cushing triad: hypertension, bradycardia, and respiratory
depression Symptoms and signs which are sometimes
present Headache Vomiting Papilledema Sixth cranial nerve palsies
Neurogenic Patterns ofRespiration
Type locationCheynes - Stokes Respiration Diffuse forebrain injury
Central neurogenic hyperventilation
Midbrain ,such as thalamus
Apneustic(pause at full inspiration)
Mid to caudal pontine, brainstem or Basilar a. occlusion
Ataxic (radom deep and shallow breaths)
Medulla lesion (terminal stage)
Cluster (irregular breaths and pause)
Lower medulla
Powerpoint Templates Page 16
Monitoring Clinical Status1. Level of alertness and GCS; 2. Pupillary examination;3. Ocular motor examination (with special attention to the third and sixth cranial nerves);4. Motor examination with special attention for hemiparesis;5. Presence of nausea or vomiting;6. Complaints of headache; and7. Current vital signs and the recent course.
Indirect Monitoring Techniques
Best to Correlate with ICP
Powerpoint Templates Page 19
Measure basal arterial cerebral blood flow,◦ 40 to 70 cm/s.
Diffuse Increase ICP compress cerebral arteries increase flow velocity
TCD is insufficiently sensitive and specific to provide a noninvasive alternative to ICP monitoring.
Transcranial Doppler ultrasonography
(TCD)
Powerpoint Templates Page 20
Direct ICP Monitoring
Neurol Clin 2008;26: 521–41
1. Fontanometry2. Epidural pressure monitoring 3. Subdural pressure monitoring 4. Parenchymal measuring5. Ventricular pressure monitoring6. Lumbar pressure monitoring
Powerpoint Templates Page 22
(1) the condition leading to ICP elevation is amenable to treatment (2) ongoing direct assessment of ICP will be
of consequence in decisions regarding treatment interventions
(3) the risks of device placement do not outweigh the potential benefits.
Indications for ICP monitoring
Neurol Clin 2008;26: 521–41
MANAGEMENT OF INCREASED
ICP
Treatment of increased ICP
The goals of ICP treatment1. Maintain ICP ≤ 20-25 mmHg.2.Maintain CPP ≥ 60 mmHg by maintaining
adequate MAP.3. Avoid factors that aggravate or
precipitate elevated ICP.
Neurol Clin 2008;26: 521–41
CPP=MAP-ICPCBF = CPP / CVR
Management of ICP Head elevation 15 ˚ - 30˚
Hyperventilation Control BP Hyperosmolar therapy Sedative and paralysis Steroid Decompressive craniectomy and lumbar
drainage
Head elevation venous out flow resistance CSF from intracranial spinal
compartment Position above heart and prevent kinking
or compression of jugular v.(c-spine precaution)The mean ICP was significantly lower when
the patient's head was elevated at 30° than at 0° (14.1 ± 6.7 mm Hg vs. 19.7 ± 8.3 mm Hg).
J Neurosurg 1992;76:207–11.
Head elevation The anesthetized or hypovolemic pts
may response to head elevation by developing systemic hypotension
Must treat to avoid adverse impact to CPP
Neurol Clin 2008;26: 521–41
Oxygenation and Ventilation Respiratory dysfunction is common esp
in head trauma. Hypoxia and hypercapnia can ICP Adequate ventilation: Pao2 ≥60 mmHg
Paco2:30-35 mmHg
Neurol Clin 2008;26: 521–41
Oxygenation and Ventilation
intrathoracic pressure are transmitted directly through the neck to the intracranial cavityIncrease intrathoracic pressure: increase ICP
decreased venous return to the right atrium and a rise in jugular venous pressure, increase in CBV and in ICP
Decreased venous return also leads to a drop in cardiac output and blood pressure, thereby reducing CPP
PEEP
Oxygenation and Ventilation The consequences of PEEP on ICP
depend on lung compliance, ICP MAP
Minimal consequences for ICP are usually observed when lung compliance is low
J Trauma 2005;58:571–6.
Hypercapnia and hypocapnia Hypercapnia
Cerebral vasodilate CBF and ICP PaCO2 1 mmHg CBF 2 ml/100g/min
In situations of reduced intracranial compliance Increased ICP and reduced CPP
In situations of reduced cerebral blood flow and oxygen delivery, where ICH is not a problem improvements in cerebral blood flow
Hyperventilation Hyperventilation PaCO2, which can induce
constriction of cerebral arteries Cerebral vasodilate CBF and ICP PaCO2 1 mmHg CBF 2 ml/100g/min PaCO2 1 mmHg CBV 0.04 ml/100g/min
Aim: Paco2 30-35 mmHg Hyperventilation may produce a decrease in CBF
sufficient to induce ischemia. Hyperventilation should be avoided during the first 24 hours after
injury when cerebral blood flow (CBF) is often critically reduced.
Neurol Clin 2008;26: 521–41
Hyperventilation Most effective use of hyperventilation is
acutely The vasoconstrictive effect :11-20 hours When hypocarbia is induced and
maintained for several hours, it should be reversed slowly, over several days, to minimize this rebound hyperemia
Prophylactic hyperventilation (PaCO2 of 25 mm Hg
or less) is not recommended.Crit Care Clin 1997;13:163–84.
Decompressive Abd Pressure intra-abdominal P.(abdominal
compartment syndrome), can ICP by obstructing cerebral venous outflow.
Immediate reductions in ICP with decompressive laparotomy
Neurol Clin 2008;26: 521–41
Decompressive Abdominal Pressure 17 pts with intractable ICH that is
refractory to medical treatment (abdominal compartment syndrome is not present)
abdominal fascial release can effectively reduce ICP (30.0±4.0 17.5±3.2)
J Trauma 2004;57:687–93.
Hyperthermia metabolic rate 10-13% per 1°C and is
a potent vasodilator. Induce dilation of cerebral vessels can CBF and ICP. Fever during the post injury period
worsens neurologic injury in TBI
Neurosurgery 1996;38:533–41
Hypothermia Prophylactic hypothermia
Not significantly associated with decrease mortality when compare with normothermic controle
Cochrane review in 2004 not find any evidence supporting the use of
hypothermia during the treatment of TBI, a statistically significant increased risk of
pneumonia and other potentially harmful side-effects
Although routine induction of hypothermia is not indicated at present,hypothermia may be an e ective ff
adjunctive treatment of increased ICP refractory to other medical management
Hypertension Common in pts who have ICH Esp 2° to HI Characterize by a SBP increase greater
than diastolic increase. Associate with sympathetic hyperactivity
Neurosurgery 1996;38:533–41.
Hypertension Not reduce BP in HT pts associated with
untreated intracranial mass lesions cerebral perfusion maintain by the
higher BP. In the absence of an intracranial mass
lesion, controversy to treat HT
Neurol Clin 2008;26:521–41
Hypertension When autoregulation is impaired,
common after TBI, HT may CBF and ICP,cerebral
edema ,risk for post-op intracranial hemorrhage
Keep SBP 120-150 mmHg
Neurol Clin 2008;26:521–41
Hypertension Vasodilating drugs e.g. nitroprusside, NTG, and
nifedipine, can ICP and catecholamines
Sympathomimetic-blocking antiHT drugs, β-blocking drugs ( esmolol) α-central acting receptor agonists (clonidine)
are preferred ( reduce BP without affecting the ICP)
Agents with a short half-life have an advantage when BP is labile.
Neurol Clin 2008;26:521–41
Treatment of anemia Mechanism: CBF for maintain cerebral
oxygen delivery when severe anemia. Anemia has not been clearly shown to
exacerbate ICP after TBI, a common practice is to maintain Hb ≥
10 g/dL.
Neurol Clin 2008;26:521–41
Prevention of seizures Seizure occur 15-20% in severe HI. Seizures can CMR and ICP In severe TBI, 50% of seizures may be
subclinical and can be detected only with continuous EEG monitoring
J Neurosurg 1999;91:750–60
Prevention of seizures Significant risk factors for later seizures
- brain contusion- subdural hematoma- depressed skull fracture- penetrating head wound- loss of consciousness or amnesia ≥1 day- age ≥ 65 years
Neurol Clin 2008;26:521–41
Barbiturates
High-dose barbiturate administration is recommended to control elevated ICP refractory to maximum standard medical and surgical treatment. Dose-dependent CBF and CMRO2 ICP by CBF and CBV Neuroprotective effect
Hemodynamic stability is essential before and during barbiturate therapy.
Barbiturate coma: EEG shows a burst suppression pattern.
Barbiturate coma Complications during treatment with
barbiturate coma include - hypotension in 58%of patients- hypokalemia in 82%- respiratory complications in 76%- infections in 55%- hepatic dysfunction in 87% - renal dysfunction in 47%
Acta Neurochir 1992;117:153–9
Propofol recommended for the control of ICP, but
not for improvement in mortality or 6 month outcome.
High-dose propofol Hypotension and propofol infusion
syndrome
Propofol infusion syndrome
Acute refractory bradycardia leading to asystole, in the presence of one or more of the following: metabolic acidosis (base deficit > 10 mmol/l), rhabdomyolysis, hyperlipidaemia, enlarged or fatty liver.
propofol infusions at doses higher than 4 mg/kg/h for greater than 48 h duration
HYPEROSMOLAR THERAPY
Mannitol onset 1-5 min peak effect 20-60 min Duration 1.5-6 hrs depending on the
clinical condition Dose:Bolus 0.25-1 g/kg Urgent reduce ICP :initial dose of 1 g/kg Can be repeated 0.25 - 0.5 g/kg q 2-6
hrs.
Neurol Clin 2008;26:521–41
Mannitol Sosm optimal is 300-320 mOsm and
should ≤ 320 mOsm to avoid S/E e.g. hypovolemia, hyperosmolarity, and renal failure.
Attention to replacing fluid that is lost because of mannitol-induced diuresis, or intravascular volume depletion
Neurol Clin 2008;26:521–41
Mannitol Osmotic effect of mannitol serum
tonicity ( draws edema fluid from cerebral parenchyma)
Neurol Clin 2008;26:521–41
Mannitol Mannitol has rheologic ( Hct and blood viscosity ( o2 delivery
to the brain) CSF production, lead to prolonged
ICP free radical scavenging effects.
Neurol Clin 2008;26:521–41
Loop diureticFurosemide Dose: 0.5-1 mg/kg Synergize with mannitol Greater ICP, less brain edema, prolong
elevation of plasma osmolarity Effect from CSF formation via alter Na+
transport across choroid plexus
Hypertonic saline Concentration 3-29.2%,
Hypertonic saline Osmotic force to draw water from the interstitial
space of the brain parenchyma into the intravascular compartment in the presence of an intact BBB
intracranial volume and ICP. augments volume resuscitation circulating BV, MAP,and CPP modulation of the inflammatory response by
adhesion of leukocytes to endothelium Effective to reduce refractory increased ICP
Anesth Analg 2006;102:1836–46
Hypertonic saline Adverse effects
- hematologic and E’lyte abnormalities HypoNa+ should be excluded before
administering HTS, to reduce the risk for central pontine myelinolysis
Serum Na is maintained 145-155 mmol/L in TBI. repeated until ICP is controlled or Na 155 mmol/L After 3–4 days of HTS therapy, boluses of
furosemide to mobilize tissue Na.
J Trauma 2001;50:367–83
Anesth Analg 2006;102:1836–46
Steroids Common use for 1° and metastatic brain
tumors Decrease vasogenic cerebral edema. ICH decreases in 2-5 days The most commonly used regimen
- Dexamethasone 4 mg q 6 hours IV.
Other neurosurgical disorders, such as TBI or spontaneous ICH- not have a benefit
Curr Opin Oncol2004;16:593–600
CSF drainage Decrease ICP immediately by reducing
intracranial volume If brain is diffuse swollen, the ventricles
may collapse, limited usefulness Special consideration
- large hemispheric mass- infratentorial mass
Result in subfalcine herniation, upward trantentorial herniation
Neurol Clin 2008;26: 521–41
Surgical interventions Resection of mass lesions Decompressive craniectomy
- Failure of medical therapy- Persistent cerebral swelling or increase ICP- Prevent transtentorial herniation
Anesthesiology Clin 2007;25: 579-603
Prevent secondary brain damaged Avoid hyper or hypoglycemia
Maintain glucose level 90-150 mg/dL A relative reduction in mortality of around
30% in patients with severe HI after the introduction of protocol
Correct electrolyte imbalance Infection control Prevent other organs dysfunction
THE END !!